Literature DB >> 11018580

Enhancing adherence in randomized controlled clinical trials.

S A Shumaker1, E Dugan, D J Bowen.   

Abstract

This paper identifies individual and systematic primary, secondary, and tertiary prevention approaches that can be used to enhance adherence in randomized controlled trials. Specifically, strategies such as these are discussed: careful screening during enrollment, use of a run-in period, fully informing participants of the study burden, explaining randomization, determining the participant's prior history with treatment interventions, establishing and using a tracking system, clearly specifying adherence measures, and staff training in communication and negotiation. These strategies have been gathered over time from our experiences working in multiple randomized controlled trials. Research on factors that promote or detract from adherence should be a standard part of randomized controlled trials. Control Clin Trials 2000;21:226S-232S

Entities:  

Mesh:

Year:  2000        PMID: 11018580     DOI: 10.1016/s0197-2456(00)00083-0

Source DB:  PubMed          Journal:  Control Clin Trials        ISSN: 0197-2456


  16 in total

1.  Use of electronic technologies to promote community and personal health for individuals unconnected to health care systems.

Authors:  John F Crilly; Robert H Keefe; Fred Volpe
Journal:  Am J Public Health       Date:  2011-05-12       Impact factor: 9.308

2.  Use of a motivational interviewing-informed strategy in group orientations to improve retention and intervention attendance in a randomized controlled trial.

Authors:  Lan Xiao; Nan Lv; Lisa G Rosas; Shweta Karve; Veronica Luna; Elizabeth Jameiro; Nancy Wittels; Jun Ma
Journal:  Health Educ Res       Date:  2016-10-10

3.  Special diabetes program for Indians: retention in cardiovascular risk reduction.

Authors:  Spero M Manson; Luohua Jiang; Lijing Zhang; Janette Beals; Kelly J Acton; Yvette Roubideaux
Journal:  Gerontologist       Date:  2011-06

4.  Subversive subjects: rule-breaking and deception in clinical trials.

Authors:  Rebecca Dresser
Journal:  J Law Med Ethics       Date:  2013       Impact factor: 1.718

5.  Adherence and renal biopsy feasibility in the Renin Angiotensin-System Study (RASS) primary prevention diabetes trial.

Authors:  William N Robiner; Trudy D Strand; Michael Mauer
Journal:  Diabetes Res Clin Pract       Date:  2013-09-17       Impact factor: 5.602

6.  Participant and site characteristics related to participant retention in a diabetes prevention translational project.

Authors:  Luohua Jiang; Spero M Manson; Edward J Dill; Janette Beals; Ann Johnson; Haixiao Huang; Kelly J Acton; Yvette Roubideaux
Journal:  Prev Sci       Date:  2015-01

7.  Strategies to retain rural breast cancer survivors in longitudinal research.

Authors:  Karen M Meneses; Rachel L Benz; Lauren A Hassey; Ziqin Q Yang; M Patrick McNees
Journal:  Appl Nurs Res       Date:  2013-09-12       Impact factor: 2.257

Review 8.  Systematic review identifies number of strategies important for retaining study participants.

Authors:  Karen A Robinson; Cheryl R Dennison; Dawn M Wayman; Peter J Pronovost; Dale M Needham
Journal:  J Clin Epidemiol       Date:  2007-05-10       Impact factor: 6.437

9.  When research meets reality-lessons learned from a pragmatic multisite group-randomized clinical trial on psychosocial interventions in the psychiatric and addiction field.

Authors:  Linda E Wüsthoff; Helge Waal; Rolf W Gråwe
Journal:  Subst Abuse       Date:  2012-08-16

10.  Factors associated with study protocol adherence and bio banking participation in reproductive medicine clinical trials and their relationship to live birth.

Authors:  Lawrence Engmann; Fangbai Sun; Richard S Legro; Michael P Diamond; Heping Zhang; Nanette Santoro
Journal:  Hum Reprod       Date:  2020-12-01       Impact factor: 6.918

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.